Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-02-13
DOI
10.1016/j.jhep.2021.12.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Cholangiocarcinoma miscoding in hepatobiliary centres
- (2020) Shaun Selvadurai et al. EJSO
- The obesity transition: stages of the global epidemic
- (2019) Lindsay M Jaacks et al. Lancet Diabetes & Endocrinology
- Diagnostic and prognostic biomarkers in cholangiocarcinoma
- (2019) Rocio I.R. Macias et al. LIVER INTERNATIONAL
- 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: systematic review and meta-analysis
- (2019) Angela Lamarca et al. JOURNAL OF HEPATOLOGY
- The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study
- (2019) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- Update on global epidemiology of viral hepatitis and preventive strategies
- (2018) Meryem Jefferies et al. World Journal of Clinical Cases
- Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2017) Wenjie Dai et al. MEDICINE
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
- (2017) Jessica L. Petrick et al. PLoS One
- CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
- (2017) Sven H. Loosen et al. Scientific Reports
- Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) J. W. Valle et al. ANNALS OF ONCOLOGY
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- Pathologic classification of cholangiocarcinoma: New concepts
- (2015) Yasuni Nakanuma et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- A New Clinically Based Staging System for Perihilar Cholangiocarcinoma
- (2014) Roongruedee Chaiteerakij et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
- (2010) Kazuhisa Uchiyama et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started